Evidence map›Paper›PMID 23845847›Full record

ArticleInternational journal of radiation oncology, biology, physics2013

The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body γ-irradiation.

Maria Moroni, Barbara F Ngudiankama, Christine Christensen, Cara H Olsen, Rossitsa Owens, Eric D Lombardini, Rebecca K Holt, Mark H Whitnall

Open access · greenAbstract readComparative Study
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mechanisms of radiation-induced endothelium damage: Emerging models and technologies.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Maria MoroniRadiation Countermeasures Program, Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. maria.moroni@usuhs.edu
Barbara F Ngudiankama
Christine Christensen
Cara H Olsen
Rossitsa Owens
Eric D Lombardini
Rebecca K Holt
Mark H Whitnall
Uniformed Services University of the Health Sciences · USArmed Forces Research Institute of Medical Science · THNational Institute of Allergy and Infectious Diseases · US

Funding

TOLL RECEPTORS IN MACROPHAGE &DENDRITIC CELL ACTIVATIONK08AI001759 · NIAID · UNIVERSITY OF WASHINGTON · PI STEVENS, ANNE MARGUERITE · 2000 to 2003
$470k
NIAID NIH HHS Y01 AI001759NIAID NIH HHS Y1-AI-1759-01
6 · The paper itself

Abstract

purposeWe are characterizing the Gottingen minipig as an additional large animal model for advanced drug testing for the acute radiation syndrome (ARS) to enhance the discovery and development of novel radiation countermeasures. Among the advantages provided by this model, the similarities to human hematologic parameters and dynamics of cell loss/recovery after irradiation provide a convenient means to compare the efficacy of drugs known to affect bone marrow cellularity and hematopoiesis. METHODS AND MATERIALS: Male Gottingen minipigs, 4 to 5 months old and weighing 9 to 11 kg, were used for this study. We tested the standard off-label treatment for ARS, rhG-CSF (Neupogen, 10 μg/kg/day for 17 days), at the estimated LD70/30 total-body γ-irradiation (TBI) radiation dose for the hematopoietic syndrome, starting 24 hours after irradiation.

resultsThe results indicated that granulocyte colony stimulating factor (G-CSF) enhanced survival, stimulated recovery from neutropenia, and induced mobilization of hematopoietic progenitor cells. In addition, the administration of G-CSF resulted in maturation of monocytes/macrophages.

conclusionsThese results support continuing efforts toward validation of the minipig as a large animal model for advanced testing of radiation countermeasures and characterization of the pathophysiology of ARS, and they suggest that the efficacy of G-CSF in improving survival after total body irradiation may involve mechanisms other than increasing the numbers of circulating granulocytes.

Indexed as

Disease Models, AnimalSwine, MiniatureAcute Radiation SyndromeAnimalsC-Reactive ProteinDrug Evaluation, PreclinicalFilgrastimGranulocyte Colony-Stimulating FactorHematopoiesisHematopoietic Stem Cell MobilizationHumansMacrophagesMaleMonocytesNeutropeniaOrgans at RiskC-Reactive ProteinFilgrastimGranulocyte Colony-Stimulating FactorRecombinant Proteins

Identifiers

PMID23845847
PMCPMC3710733
OpenAlexW1974837400

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.